Phase IIb study of lebrikizumab in moderate to severe atopic dermatitis meets primary endpoint March 18, 2019
FDA approves Dupixent for use in adolescents with moderate to severe atopic dermatitis March 12, 2019
New variant of genetic mutation in the ANTXR2 gene found to be associated with hyaline fibromatosis March 8, 2019
RSS